Sept 19 (Reuters) - Revive Therapeutics Ltd RVV.V
* Revive Therapeutics and South Carolina Research Foundation enter into exclusive license agreement for cannabinoids-based therapeutics in the treatment of liver diseases
* Revive Therapeutics Ltd - Revive will pay SCRF a nominal one time fee for entering into license
* Revive Therapeutics Ltd - future payments will be based on clinical trial and revenue milestones reached by Revive in future
* Revive Therapeutics - will acquire exclusive license from SCRF to develop, commercialize portfolio of patents based on cannabinoid-based therapeutics